Research we're watching
During a procedure to restore blood flow to the heart (angioplasty), doctors nearly always insert a wire-mesh tube called a stent to hold the artery open. In July, the FDA approved the first stent made of a biodegradable substance that is believed to fully dissolve in about three years.
Like a traditional drug-eluting metal stent, the new absorbable stent temporarily releases a drug that helps prevent scarring inside the newly opened artery. In a trial of 2,008 people that compared the absorbable stent with a drug-eluting metal one, rates of heart attacks and other serious heart-related events were roughly the same in both groups after one year. But the risk of blood clot formation was about twice as likely inside the absorbable stent (1.5%) compared with the metal stent (0.74%).
Patients aren't normally offered a choice of which type of stent they receive, as doctors typically make that decision. Cost may be a factor, as new products are usually more expensive than older ones. For now, many experts believe it is best to wait until more long-term results are available before routinely using an absorbable stent.
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review on all articles. No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.